Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
6 citing papers in PubMed, 9 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors at 3 institutions in 3 countries.
Matthew T LewisDivision of Geriatrics, Department of Medicine, University of Utah, Salt Lake City, Utah.ORCID 0000-0003-0580-6866
Gregory M BlainLAMHESS, University Nice Sophia Antipolis, Nice, France.
Corey R HartGeriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, Salt Lake City, Utah.
Gwenael LayecDivision of Geriatrics, Department of Medicine, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-5029-2457
Matthew J RossmanGeriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, Salt Lake City, Utah.
Song-Young ParkGeriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, Salt Lake City, Utah.
Joel D TrinityDivision of Geriatrics, Department of Medicine, University of Utah, Salt Lake City, Utah.ORCID 0000-0001-8271-6536
Jayson R GiffordGeriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, Salt Lake City, Utah.
Simranjit K SidhuDivision of Geriatrics, Department of Medicine, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-4797-8298
Joshua C WeavilGeriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, Salt Lake City, Utah.ORCID 0000-0002-2032-8498
Thomas J HureauDivision of Geriatrics, Department of Medicine, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-6993-5723
Jacob E JessopDepartment of Anesthesiology, University of Utah, Salt Lake City, Utah.
Amber D BledsoeDepartment of Anesthesiology, University of Utah, Salt Lake City, Utah.
Markus AmannDivision of Geriatrics, Department of Medicine, University of Utah, Salt Lake City, Utah.
Russell S RichardsonDivision of Geriatrics, Department of Medicine, University of Utah, Salt Lake City, Utah.
University of Utah · USUniversité de Toulon · FRUniversity of Nebraska at Omaha · US
Funding
Tissue Imaging, Biochemistry and MorphologyP01HL091830 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WAGNER, PETER D · 2009 to 2013
$10.1M
Role of Sensory Neurons in Human Cardiovascular DiseaseR01HL116579 · NHLBI · UNIVERSITY OF UTAH · PI AMANN, MARKUS · 2013 to 2021
$3.4M
Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction during DisuseR01HL142603 · NHLBI · UNIVERSITY OF UTAH · PI TRINITY, JOEL DOUGLAS · 2019 to 2023
$2.9M
Cardiovasomobility Research Training ProgramT32HL139451 · NHLBI · UNIVERSITY OF UTAH · PI SUPIANO, MARK A, WRAY, D. WALTER · 2018 to 2022
$1.4M
Nitric oxide coupling and BH4 availability roles in muscle dysfunction with COPDR00HL125756 · NHLBI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI LAYEC, GWENAEL · 2018 to 2020
$738k
Work of Breathing and Oxidative Stress in COPD: Impact on Blood Flow and FatigueR00HL103786 · NHLBI · UNIVERSITY OF UTAH · PI AMANN, MARKUS · 2013 to 2015
$738k
Agilent 6550 QTOF system for U of UtahS10OD016232 · OD · UNIVERSITY OF UTAH · PI COX, JAMES ERIC · 2013 to 2013
$578k
Nitric oxide coupling and BH4 availability roles in muscle dysfunction with COPDK99HL125756 · NHLBI · UNIVERSITY OF UTAH · PI LAYEC, GWENAEL · 2015 to 2016
$300k
Respiratory muscle work and oxidative stress in COPD: impact on leg blood flow anK99HL103786 · NHLBI · UNIVERSITY OF UTAH · PI AMANN, MARKUS · 2010 to 2011
$161k
Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction during DisuseI01CX001999 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI TRINITY, JOEL DOUGLAS · 2019 to 2023
–
Premature fatigue in veterans with heart failure: neuronal influencesI21RX001572 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI AMANN, MARKUS · 2015 to 2016
–
CSRD VA I01 CX001999HHS | NIH | National Center for Research Resources (NCRR) S10 OD016232-01HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL-091830HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL-103786HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL-116579HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL-125756HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL-142603NHLBI NIH HHS K99 HL103786NHLBI NIH HHS K99 HL125756NHLBI NIH HHS P01 HL091830NHLBI NIH HHS R00 HL103786NHLBI NIH HHS R00 HL125756NHLBI NIH HHS R01 HL116579NHLBI NIH HHS R01 HL142603NHLBI NIH HHS T32 HL139451NIH HHS S10 OD016232RRD VA I21 RX001572
6 · The paper itself
Abstract
Recently it was documented that fatiguing, high-intensity exercise resulted in a significant attenuation in maximal skeletal muscle mitochondrial respiratory capacity, potentially due to the intramuscular metabolic perturbation elicited by such intense exercise. With the utilization of intrathecal fentanyl to attenuate afferent feedback from group III/IV muscle afferents, permitting increased muscle activation and greater intramuscular metabolic disturbance, this study aimed to better elucidate the role of metabolic perturbation on mitochondrial respiratory function. Eight young, healthy males performed high-intensity cycle exercise in control (CTRL) and fentanyl-treated (FENT) conditions. Liquid chromatography-mass spectrometry and high-resolution respirometry were used to assess metabolites and mitochondrial respiratory function, respectively, pre- and postexercise in muscle biopsies from the vastus lateralis. Compared with CTRL, FENT yielded a significantly greater exercise-induced metabolic perturbation (PCr: -67% vs. -82%, Pi: 353% vs. 534%, pH: -0.22 vs. -0.31, lactate: 820% vs. 1,160%). Somewhat surprisingly, despite this greater metabolic perturbation in FENT compared with CTRL, with the only exception of respiratory control ratio (RCR) (-3% and -36%) for which the impact of FENT was significantly greater, the degree of attenuated mitochondrial respiratory capacity postexercise was not different between CTRL and FENT, respectively, as assessed by maximal respiratory flux through complex I (-15% and -33%), complex II (-36% and -23%), complex I + II (-31% and -20%), and state 3
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Acute high-intensity exercise and skeletal muscle mitochondrial respiratory function: role of metabolic perturbation. · full record | OpenQuestion